{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:08:21Z","timestamp":1788476901944,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82230125"],"award-info":[{"award-number":["82230125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05038-y","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:30:39Z","timestamp":1754487039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effects of Songling Xuemaikang capsule on vascular remodeling of stage 1 hypertension: a multicenter, randomized placebo-controlled trial protocol"],"prefix":"10.1186","volume":"25","author":[{"given":"Qiyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wende","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"10304","key":"5038_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"Worldwide trends in","year":"2021","unstructured":"Worldwide trends in. Hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957\u201380.","journal-title":"Lancet"},{"issue":"24","key":"5038_CR2","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1097\/CM9.0000000000002927","volume":"136","author":"Z Wang","year":"2023","unstructured":"Wang Z, Ma L, Liu M, Fan J, Hu S. Summary of the 2022 report on cardiovascular health and diseases in China. Chin Med J (Engl). 2023;136(24):2899\u2013908.","journal-title":"Chin Med J (Engl)"},{"issue":"33","key":"5038_CR3","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"12","key":"5038_CR4","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, Tsioufis K, Agabiti-Rosei E, Algharably EAE, et al. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society Of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens"},{"issue":"7","key":"5038_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCULATIONAHA.117.030898","volume":"137","author":"R Pazoki","year":"2018","unstructured":"Pazoki R, Dehghan A, Evangelou E, Warren H, Gao H, Caulfield M, Elliott P, Tzoulaki I. Genetic predisposition to high blood pressure and lifestyle factors: associations with midlife blood pressure levels and cardiovascular events. Circulation. 2018;137(7):653\u201361.","journal-title":"Circulation"},{"key":"5038_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40885-020-00141-3","volume":"26","author":"J Liu","year":"2020","unstructured":"Liu J. Highlights of the 2018 Chinese hypertension guidelines. Clin Hypertens. 2020;26:8.","journal-title":"Clin Hypertens"},{"issue":"6","key":"5038_CR7","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.116.303596","volume":"116","author":"S Laurent","year":"2015","unstructured":"Laurent S, Boutouyrie P. The structural factor of hypertension: large and small artery alterations. Circ Res. 2015;116(6):1007\u201321.","journal-title":"Circ Res"},{"issue":"9","key":"5038_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/2012.jama.10503","volume":"308","author":"BM Kaess","year":"2012","unstructured":"Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS, Mitchell GF. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308(9):875\u201381.","journal-title":"JAMA"},{"issue":"14","key":"5038_CR9","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jacc.2007.10.065","volume":"51","author":"SS Najjar","year":"2008","unstructured":"Najjar SS, Scuteri A, Shetty V, Wright JG, Muller DC, Fleg JL, Spurgeon HP, Ferrucci L, Lakatta EG. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore longitudinal study of aging. J Am Coll Cardiol. 2008;51(14):1377\u201383.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5038_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/aje\/kwv274","volume":"183","author":"W Chen","year":"2016","unstructured":"Chen W, Li S, Fernandez C, Sun D, Lai CC, Zhang T, Bazzano L, Urbina EM, Deng HW. Temporal relationship between elevated blood pressure and arterial stiffening among middle-aged black and white adults: the Bogalusa heart study. Am J Epidemiol. 2016;183(7):599\u2013608.","journal-title":"Am J Epidemiol"},{"issue":"35","key":"5038_CR11","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehaa238","volume":"41","author":"M Cecelja","year":"2020","unstructured":"Cecelja M, Keehn L, Ye L, Spector TD, Hughes AD, Chowienczyk P. Genetic aetiology of blood pressure relates to aortic stiffness with bi-directional causality: evidence from heritability, blood pressure polymorphisms, and Mendelian randomization. Eur Heart J. 2020;41(35):3314\u201322.","journal-title":"Eur Heart J"},{"issue":"7","key":"5038_CR12","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/CIRCRESAHA.121.318061","volume":"128","author":"P Boutouyrie","year":"2021","unstructured":"Boutouyrie P, Chowienczyk P, Humphrey JD, Mitchell GF. Arterial stiffness and cardiovascular risk in hypertension. Circ Res. 2021;128(7):864\u201386.","journal-title":"Circ Res"},{"key":"5038_CR13","doi-asserted-by":"crossref","unstructured":"Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, Heffernan KS, Lakatta EG, McEniery CM, Mitchell GF et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66(3):698\u2013722.","DOI":"10.1161\/HYP.0000000000000033"},{"issue":"6","key":"5038_CR14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.117.09097","volume":"69","author":"T Ohkuma","year":"2017","unstructured":"Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, et al. Brachial-ankle pulse wave velocity and the risk prediction of cardiovascular disease: an individual participant data meta-analysis. Hypertension. 2017;69(6):1045\u201352.","journal-title":"Hypertension"},{"issue":"4","key":"5038_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/HYPERTENSIONAHA.114.03282","volume":"64","author":"S Laurent","year":"2014","unstructured":"Laurent S, Boutouyrie P. Dose-dependent arterial destiffening and inward remodeling after olmesartan in hypertensives with metabolic syndrome. Hypertension. 2014;64(4):709\u201316.","journal-title":"Hypertension"},{"issue":"5","key":"5038_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jacc.2008.09.046","volume":"53","author":"A Protogerou","year":"2009","unstructured":"Protogerou A, Blacher J, Stergiou GS, Achimastos A, Safar ME. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in regression of arterial stiffness in a controlled double-blind) study. J Am Coll Cardiol. 2009;53(5):445\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5038_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrcardio.2017.120","volume":"15","author":"FZ Marques","year":"2018","unstructured":"Marques FZ, Mackay CR, Kaye DM. Beyond gut feelings: how the gut microbiota regulates blood pressure. Nat Rev Cardiol. 2018;15(1):20\u201332.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"5038_CR18","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.118.12109","volume":"73","author":"S Sun","year":"2019","unstructured":"Sun S, Lulla A, Sioda M, Winglee K, Wu MC, Jacobs DR Jr., Shikany JM, Lloyd-Jones DM, Launer LJ, Fodor AA, et al. Gut microbiota composition and blood pressure. Hypertension. 2019;73(5):998\u20131006.","journal-title":"Hypertension"},{"issue":"1","key":"5038_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14.","journal-title":"Microbiome"},{"issue":"25","key":"5038_CR20","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1093\/eurheartj\/ehy226","volume":"39","author":"C Menni","year":"2018","unstructured":"Menni C, Lin C, Cecelja M, Mangino M, Matey-Hernandez ML, Keehn L, Mohney RP, Steves CJ, Spector TD, Kuo CF, et al. Gut microbial diversity is associated with lower arterial stiffness in women. Eur Heart J. 2018;39(25):2390\u20137.","journal-title":"Eur Heart J"},{"issue":"6","key":"5038_CR21","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","volume":"65","author":"T Yang","year":"2015","unstructured":"Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, Zadeh M, Gong M, Qi Y, Zubcevic J, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331\u201340.","journal-title":"Hypertension"},{"key":"5038_CR22","doi-asserted-by":"publisher","first-page":"110503","DOI":"10.1016\/j.biopha.2020.110503","volume":"130","author":"F Yang","year":"2020","unstructured":"Yang F, Chen H, Gao Y, An N, Li X, Pan X, Yang X, Tian L, Sun J, Xiong X, et al. Gut microbiota-derived short-chain fatty acids and hypertension: mechanism and treatment. Biomed Pharmacother. 2020;130:110503.","journal-title":"Biomed Pharmacother"},{"issue":"24","key":"5038_CR23","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","volume":"69","author":"P Hao","year":"2017","unstructured":"Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y. Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J Am Coll Cardiol. 2017;69(24):2952\u201366.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"5038_CR24","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.120.046685","volume":"142","author":"DY Zhang","year":"2020","unstructured":"Zhang DY, Cheng YB, Guo QH, Shan XL, Wei FF, Lu F, Sheng CS, Huang QF, Yang CH, Li Y, et al. Treatment of masked hypertension with a Chinese herbal formula: a randomized, placebo-controlled trial. Circulation. 2020;142(19):1821\u201330.","journal-title":"Circulation"},{"key":"5038_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.phrs.2019.02.024","volume":"142","author":"W Feng","year":"2019","unstructured":"Feng W, Ao H, Peng C, Yan D. Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol Res. 2019;142:176\u201391.","journal-title":"Pharmacol Res"},{"key":"5038_CR26","doi-asserted-by":"publisher","first-page":"154459","DOI":"10.1016\/j.phymed.2022.154459","volume":"107","author":"T Meng","year":"2022","unstructured":"Meng T, Wang P, Xie X, Li T, Kong L, Xu Y, Cao K, Gao Y, He Q, Lai X. Efficacy and safety of Songling Xuemaikang capsule for essential hypertension: a systematic review and meta-analysis of randomized controlled trials. Phytomedicine. 2022;107:154459.","journal-title":"Phytomedicine"},{"issue":"3","key":"5038_CR27","doi-asserted-by":"publisher","first-page":"e007923","DOI":"10.1161\/CIRCOUTCOMES.121.007923","volume":"15","author":"X Lai","year":"2022","unstructured":"Lai X, Dong Z, Wu S, Zhou X, Zhang G, Xiong S, Wu W, Cao R, Wang X, Hua Q, et al. Efficacy and safety of Chinese herbal medicine compared with losartan for mild essential hypertension: a randomized, multicenter, double-blind, noninferiority trial. Circ Cardiovasc Qual Outcomes. 2022;15(3):e007923.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"5038_CR28","first-page":"660","volume":"21","author":"WQ Chen","year":"2001","unstructured":"Chen WQ, Chen FR. Effect of Songling Xuemaikang capsule combined with captopril on quality of life in primary hypertension patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001;21(9):660\u20132.","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"5038_CR29","doi-asserted-by":"publisher","first-page":"112660","DOI":"10.1016\/j.jep.2020.112660","volume":"253","author":"J Qi","year":"2020","unstructured":"Qi J, Tan Y, Fan D, Pan W, Yu J, Xu W, Wu J, Zhang M. Songling Xuemaikang capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKII\u03b4 and ERK1\/2 pathways. J Ethnopharmacol. 2020;253:112660.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"5038_CR30","first-page":"488","volume":"17","author":"LT Liu","year":"2018","unstructured":"Liu LT, Liang L, Wang W, Yan CQ, Zhang J, Xiao YC, Ye L, Zhao MX, Huang QS, Bian JJ, et al. Isolariciresinol-9\u2019-O-\u03b1-L-arabinofuranoside protects against hydrogen peroxide\u2013induced apoptosis of human umbilical vein endothelial cells via a PI3K\/Akt\/Bad\u2013dependent pathway. Mol Med Rep. 2018;17(1):488\u201394.","journal-title":"Mol Med Rep"},{"issue":"3","key":"5038_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1161\/HYPERTENSIONAHA.110.163402","volume":"57","author":"WB White","year":"2011","unstructured":"White WB, Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension. 2011;57(3):413\u201320.","journal-title":"Hypertension"},{"issue":"4","key":"5038_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jacc.2015.10.083","volume":"67","author":"AK Pareek","year":"2016","unstructured":"Pareek AK, Messerli FH, Chandurkar NB, Dharmadhikari SK, Godbole AV, Kshirsagar PP, Agarwal MA, Sharma KH, Mathur SL, Kumbla MM. Efficacy of low-dose chlorthalidone and hydrochlorothiazide as assessed by 24-h ambulatory blood pressure monitoring. J Am Coll Cardiol. 2016;67(4):379\u201389.","journal-title":"J Am Coll Cardiol"},{"issue":"10393","key":"5038_CR33","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(23)00733-X","volume":"401","author":"N Staplin","year":"2023","unstructured":"Staplin N, de la Sierra A, Ruilope LM, Emberson JR, Vinyoles E, Gorostidi M, Ruiz-Hurtado G, Segura J, Baigent C, Williams B. Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients. Lancet. 2023;401(10393):2041\u201350.","journal-title":"Lancet"},{"issue":"9","key":"5038_CR34","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1291\/hypres.31.1753","volume":"31","author":"Y Kawano","year":"2008","unstructured":"Kawano Y, Sato Y, Yoshinaga K. A randomized trial of the effect of an angiotensin II receptor blocker SR47436 (irbesartan) on 24-hour blood pressure in patients with essential hypertension. Hypertens Res. 2008;31(9):1753\u201363.","journal-title":"Hypertens Res"},{"issue":"5","key":"5038_CR35","first-page":"799","volume":"41","author":"GH Zhu","year":"2021","unstructured":"Zhu GH, Sun XP, Ding CT, Zhao H, Li J, Hua Q. Effect of Songlingxuemaikang on mild essential hypertension in patients: a randomized parallel-controlled study. J Tradit Chin Med. 2021;41(5):799\u2013805.","journal-title":"J Tradit Chin Med"},{"issue":"1","key":"5038_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13020-021-00431-4","volume":"16","author":"J Yao","year":"2021","unstructured":"Yao J, Zhang C, Yang Y, Fang X, Chen Q, Zhong G. Comparative transcriptomic analysis revealed novel potential therapeutic targets of traditional Chinese medicine (Pinggan-Qianyang decoction) on vascular remodeling in spontaneously hypertensive rats. Chin Med. 2021;16(1):21.","journal-title":"Chin Med"},{"key":"5038_CR37","doi-asserted-by":"publisher","first-page":"113802","DOI":"10.1016\/j.biopha.2022.113802","volume":"155","author":"W Liu","year":"2022","unstructured":"Liu W, Xu S, Liang S, Duan C, Xu Z, Zhao L, Wen F, Li Q, Li Y, Zhang J. Hypertensive vascular and cardiac remodeling protection by allicin in spontaneous hypertension rats via CaMK II\/NF-\u03baB pathway. Biomed Pharmacother. 2022;155:113802.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5038_CR38","doi-asserted-by":"publisher","first-page":"2249269","DOI":"10.1080\/10641963.2023.2249269","volume":"45","author":"X Lai","year":"2023","unstructured":"Lai X, Fang Z, Dong Z, Wu S, Zhou X, Gao Y. A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal medicine: comparing the real-world registry data vs. randomized controlled trial. Clin Exp Hypertens. 2023;45(1):2249269.","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"5038_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/00004872-199502000-00015","volume":"13","author":"A Prasad","year":"1995","unstructured":"Prasad A, Dunnill GS, Mortimer PS, MacGregor GA. Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens. 1995;13(2):265\u20138.","journal-title":"J Hypertens"},{"issue":"8","key":"5038_CR40","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1172\/JCI119354","volume":"99","author":"JP Noon","year":"1997","unstructured":"Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest. 1997;99(8):1873\u20139.","journal-title":"J Clin Invest"},{"issue":"1","key":"5038_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0008-6363(00)00198-X","volume":"49","author":"EH Sern\u00e9","year":"2001","unstructured":"Sern\u00e9 EH, Gans RO, ter Maaten JC, ter Wee PM, Donker AJ, Stehouwer CD. Capillary recruitment is impaired in essential hypertension and relates to insulin\u2019s metabolic and vascular actions. Cardiovasc Res. 2001;49(1):161\u20138.","journal-title":"Cardiovasc Res"},{"issue":"4 Pt 1","key":"5038_CR42","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1161\/01.HYP.34.4.655","volume":"34","author":"TF Antonios","year":"1999","unstructured":"Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension. 1999;34(4 Pt 1):655\u20138.","journal-title":"Hypertension"},{"issue":"1","key":"5038_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/mvre.1993.1001","volume":"45","author":"AG Hudetz","year":"1993","unstructured":"Hudetz AG. Percolation phenomenon: the effect of capillary network rarefaction. Microvasc Res. 1993;45(1):1\u201310.","journal-title":"Microvasc Res"},{"issue":"11","key":"5038_CR44","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1136\/gutjnl-2020-323314","volume":"70","author":"F Brial","year":"2021","unstructured":"Brial F, Chilloux J, Nielsen T, Vieira-Silva S, Falony G, Andrikopoulos P, Olanipekun M, Hoyles L, Djouadi F, Neves AL, et al. Human and preclinical studies of the host-gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health. Gut. 2021;70(11):2105\u201314.","journal-title":"Gut"},{"issue":"6657","key":"5038_CR45","doi-asserted-by":"publisher","first-page":"eadd5787","DOI":"10.1126\/science.add5787","volume":"381","author":"K Wang","year":"2023","unstructured":"Wang K, Zhang Z, Hang J, Liu J, Guo F, Ding Y, Li M, Nie Q, Lin J, Zhuo Y, et al. Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target. Sci (New York NY). 2023;381(6657):eadd5787.","journal-title":"Sci (New York NY)"},{"issue":"75","key":"5038_CR46","doi-asserted-by":"publisher","first-page":"eabn0704","DOI":"10.1126\/sciimmunol.abn0704","volume":"7","author":"G Mirji","year":"2022","unstructured":"Mirji G, Worth A, Bhat SA, El Sayed M, Kannan T, Goldman AR, Tang HY, Liu Q, Auslander N, Dang CV, et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Sci Immunol. 2022;7(75):eabn0704.","journal-title":"Sci Immunol"},{"issue":"1","key":"5038_CR47","doi-asserted-by":"publisher","first-page":"2195135","DOI":"10.1080\/10641963.2023.2195135","volume":"45","author":"Z Yang","year":"2023","unstructured":"Yang Z, Wang Q, Liu Y, Wang L, Ge Z, Li Z, Feng S, Wu C. Gut microbiota and hypertension: association, mechanisms and treatment. Clin Exp Hypertens. 2023;45(1):2195135.","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"5038_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/CIRCRESAHA.122.321975","volume":"132","author":"S Luo","year":"2023","unstructured":"Luo S, Zhao Y, Zhu S, Liu L, Cheng K, Ye B, Han Y, Fan J, Xia M. Flavonifractor plautii protects against elevated arterial stiffness. Circ Res. 2023;132(2):167\u201381.","journal-title":"Circ Res"},{"key":"5038_CR49","doi-asserted-by":"crossref","unstructured":"Robles-Vera I, de la Visitaci\u00f3n N, Toral M, S\u00e1nchez M, Romero M, G\u00f3mez-Guzm\u00e1n M, Vargas F, Duarte J, Jim\u00e9nez R. Changes in gut microbiota induced by doxycycline influence in vascular function and development of hypertension in DOCA-salt rats. Nutrients. 2021;13(9).","DOI":"10.3390\/nu13092971"},{"issue":"1","key":"5038_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13880209.2022.2099430","volume":"61","author":"J Li","year":"2023","unstructured":"Li J, Li Y, Yuan X, Yao D, Gao Z, Niu Z, Wang Z, Zhang Y. The effective constituent puerarin, from Pueraria lobata, inhibits the proliferation and inflammation of vascular smooth muscle in atherosclerosis through the miR-29b-3p\/IGF1 pathway. Pharm Biol. 2023;61(1):1\u201311.","journal-title":"Pharm Biol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05038-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:26:37Z","timestamp":1757345197000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-05038-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5038"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05038-y","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the central IEC of Xiyuan Hospital of China Academy of Chinese Medical Sciences (Approval No. 2023.09.14v3.0). Participants will be asked to sign an informed consent(s) before participating in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No data are presented in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"300"}}